Detalhe da pesquisa
1.
Financing and Reimbursement of Approved Advanced Therapies in Several European Countries.
Value Health
; 26(6): 841-853, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36646280
2.
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States.
Cytotherapy
; 23(3): 261-274, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483292
3.
Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies.
BMC Health Serv Res
; 21(1): 814, 2021 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391431
4.
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.
Br J Clin Pharmacol
; 86(6): 1034-1051, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162368
5.
Amyloid-induced ß-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment.
FASEB J
; 31(12): 5296-5306, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28821639
6.
The impact of parallel regulatory-health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations.
Br J Clin Pharmacol
; 84(5): 1013-1019, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370449
7.
Insulin-like Growth Factor 2 Overexpression Induces ß-Cell Dysfunction and Increases Beta-cell Susceptibility to Damage.
J Biol Chem
; 290(27): 16772-85, 2015 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25971976
8.
How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory-HTA parallel scientific advice.
Br J Clin Pharmacol
; 82(4): 965-73, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27245362
9.
Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells.
Biochem J
; 442(2): 345-56, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22115192
10.
Reporting reimbursement price decisions for onco-hematology drugs in Spain.
Front Public Health
; 11: 1265323, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942255
11.
Early Access to Medicines: Use of Multicriteria Decision Analysis (MCDA) as a Decision Tool in Catalonia (Spain).
J Clin Med
; 11(5)2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35268443
12.
Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue.
Redox Biol
; 54: 102353, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777200
13.
Current landscape of clinical development and approval of advanced therapies.
Mol Ther Methods Clin Dev
; 23: 606-618, 2021 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34901306
14.
Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union.
Front Pharmacol
; 12: 773712, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916948
15.
Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.
Front Pharmacol
; 11: 766, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32523535
16.
Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and ß-cell dysfunction.
Mol Metab
; 37: 100984, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32229246
17.
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab.
Appl Health Econ Health Policy
; 18(1): 5-16, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696433
18.
Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.
Front Pharmacol
; 10: 921, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31543814
19.
Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut).
Orphanet J Rare Dis
; 14(1): 157, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248421
20.
Characterization of a new liver- and kidney-specific pfkfb3 isozyme that is downregulated by cell proliferation and dedifferentiation.
Biochem Biophys Res Commun
; 367(4): 748-54, 2008 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-18191036